Literature DB >> 18728293

Medicare part D and the nursing home setting.

David G Stevenson1, Haiden A Huskamp, Joseph P Newhouse.   

Abstract

PURPOSE: The purpose of this article is to explore how the introduction of Medicare Part D is changing the operations of long-term-care pharmacies (LTCPs) and nursing homes, as well as implications of those changes for nursing home residents. DESIGN AND METHODS: We reviewed existing sources of information and interviewed stakeholders across various perspectives. We conducted 31 semistructured telephone interviews with key stakeholders between November 2006 and January 2007.
RESULTS: Part D represents a substantial departure from how prescription drugs were previously financed and administered in nursing homes, and nursing home providers and LTCPs have struggled in adapting to some of these changes. Part D increased the variation around formularies and drug management processes for residents at the facility level, creating additional burden on clinical and pharmacy staff and introducing a tension between facilities' need to dispense medications quickly and assuring of coverage for those drugs. Nursing home and LTCP stakeholders perceive wide variation across Part D plans in their ability to meet the needs of nursing home residents. IMPLICATIONS: Although LTCPs, nursing homes and their clinicians, and Part D plans will gain experience with the benefit in the nursing home setting over time, stakeholders we interviewed identified a range of longer term issues and questions that merit attention as the benefit proceeds.

Entities:  

Mesh:

Year:  2008        PMID: 18728293      PMCID: PMC2538577          DOI: 10.1093/geront/48.4.432

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  7 in total

1.  Incidence and preventability of adverse drug events in nursing homes.

Authors:  J H Gurwitz; T S Field; J Avorn; D McCormick; S Jain; M Eckler; M Benser; A C Edmondson; D W Bates
Journal:  Am J Med       Date:  2000-08-01       Impact factor: 4.965

2.  Prescription drugs in nursing homes: managing costs and quality in a complex environment.

Authors:  Dan Mendelson; Rajeev Ramchand; Richard Abramson; Anne Tumlinson
Journal:  NHPF Issue Brief       Date:  2002-11-12

3.  The National Nursing Home Survey: 1999 summary.

Authors:  Adrienne Jones
Journal:  Vital Health Stat 13       Date:  2002-06

4.  The incidence of adverse drug events in two large academic long-term care facilities.

Authors:  Jerry H Gurwitz; Terry S Field; James Judge; Paula Rochon; Leslie R Harrold; Cynthia Cadoret; Monica Lee; Kathleen White; Jane LaPrino; Janet Erramuspe-Mainard; Martin DeFlorio; Linda Gavendo; Jill Auger; David W Bates
Journal:  Am J Med       Date:  2005-03       Impact factor: 4.965

5.  Coverage and use of prescription drugs in nursing homes: implications for the medicare modernization act.

Authors:  Bruce Stuart; Linda Simoni-Wastila; Fatima Baysac; Thomas Shaffer; Dennis Shea
Journal:  Med Care       Date:  2006-03       Impact factor: 2.983

Review 6.  Drug use in the nursing home.

Authors:  J Avorn; J H Gurwitz
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

7.  Medicare Part D and nursing home residents.

Authors:  David G Stevenson; Haiden A Huskamp; Nancy L Keating; Joseph P Newhouse
Journal:  J Am Geriatr Soc       Date:  2007-07       Impact factor: 5.562

  7 in total
  7 in total

Review 1.  Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence.

Authors:  Camilla B Pimentel; Kate L Lapane; Becky A Briesacher
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

2.  Adequacy of Prescription Drug Coverage in Long-term Care.

Authors:  Becky Briesacher; Brianne Oliveri-Mui; Bhavika Chhabra; Benjamin Koethe
Journal:  Med Care       Date:  2020-05       Impact factor: 2.983

3.  Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes.

Authors:  David G Stevenson; A James O'Malley; Stacie B Dusetzina; Susan L Mitchell; Barbara J Zarowitz; Michael E Chernew; Joseph P Newhouse; Haiden A Huskamp
Journal:  J Am Geriatr Soc       Date:  2014-08-14       Impact factor: 5.562

4.  Nursing home residents and enrollment in Medicare Part D.

Authors:  Becky A Briesacher; Stephen B Soumerai; Terry S Field; Hassan Fouayzi; Jerry H Gurwitz
Journal:  J Am Geriatr Soc       Date:  2009-08-21       Impact factor: 5.562

5.  Medicare Part D claims rejections for nursing home residents, 2006 to 2010.

Authors:  David G Stevenson; Laura M Keohane; Susan L Mitchell; Barbara J Zarowitz; Haiden A Huskamp
Journal:  Am J Manag Care       Date:  2012-10       Impact factor: 2.229

6.  Antimicrobial Use in a Cohort of US Nursing Homes, 2017.

Authors:  Nicola D Thompson; Nimalie D Stone; Cedric J Brown; Austin R Penna; Taniece R Eure; Wendy M Bamberg; Grant R Barney; Devra Barter; Paula Clogher; Malini B DeSilva; Ghinwa Dumyati; Linda Frank; Christina B Felsen; Deborah Godine; Lourdes Irizarry; Marion A Kainer; Linda Li; Ruth Lynfield; J P Mahoehney; Meghan Maloney; Joelle Nadle; Valerie L S Ocampo; Rebecca Pierce; Susan M Ray; Sarah Shrum Davis; Marla Sievers; Krithika Srinivasan; Lucy E Wilson; Alexia Y Zhang; Shelley S Magill
Journal:  JAMA       Date:  2021-04-06       Impact factor: 56.272

7.  The impact of Medicare part D prescription drug benefit program on generic drug prescription: A study in long-term care facilities.

Authors:  Changmi Jung; Rema Padman; Shamena Anwar
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.